Contributor's Links: White Diamond Research

White Diamond Research looks for special situations and stocks with the potential for big moves in the near future up or down. We specialize in the technology, energy and health care sectors, since those have the most interesting, misunderstood companies. However, we research special situations ... more

ALL CONTRIBUTIONS

New Age Beverages Is About To Take A Spill After Parabolic Rise With Many Upcoming Negative Catalysts
The Company’s recent ‘key’ licensing deal to sell Marley branded CBD drinks comes with unfavorable economics as NBEV will pay a high 50% of gross margin for the license.
Read
Delcath Systems Share Price Has Risen Over 1000% In The Past Month On No News And Is Engaged In Death Spiral Financing
Delcath is engaging in death spiral financing, and the convertible note holders can buy shares at a 15% discount to the recent market price and immediately sell. It's clinical trials are on the same technology that the FDA failed to approve in 2013.
Read
PDL BioPharma Is A Solid Biotech Investment In A Friendly Regulatory Environment
Despite reaching a low in its downtrend, PDL expects to remain profitable, has a large cash position, and a share buyback is in place.
Read
If Ominto Was A Private Company It Would Be Worth A Fraction Of Its Current Price
For the past four years, Ominot has had miniscule to no growth, only about $20 million per year in revenues, and loses about $10 million per year. We estimate Ominto’s value to be $1-$2 per share, for an eventual 90% decline.
Read

Comments

Latest Comments
New Age Beverages Is About To Take A Spill After Parabolic Rise With Many Upcoming Negative Catalysts
2 months ago

Thanks for the comments. Yes, Bart that info will be shown in our Seeking Alpha article that will be off embargo tomorrow at 10am:

seekingalpha.com/.../4238331-new-age-beverages-take-spill-parabolic-rise-upcoming-negative-catalysts

In this article: NBEV
1 to 1 of 1 comments

STOCKS I FOLLOW

AAC Australia Acquisition Corp.
ACHC Acadia Healthcare Company, Inc.
CRRVF CVR Medical Corp.
DCTH Delcath Systems Inc.
DEPO Depomed Inc.
GRST GREENESTONE HEALTH
HZNP Horizon Pharma
IBB iShares Nasdaq Biotechnology Index Fund
MNKD MannKind Corporation
MTNB Matinas BioPharma Holdings, Inc.
NULF Nu Life Sciences Inc
NVS Novartis AG
OMNT Ominto, Inc.
ONCS ONCOSEC MEDICAL
PDLI PDL BioPharma Inc.
PRGO Perrigo Company
RLYP Relypsa, Inc.
SGMS Scientific Games Corp
STRP STRATA CAPITAL CORP
SYMX Synthesis Energy Systems Inc.
VRX Valeant Pharmaceuticals International Inc.
VTGN VistaGen Therapeutics, Inc
Load More

TWEETS

LATEST ACTIVITY

White Diamond Research Commented on New Age Beverages Is About To Take A Spill After Parabolic Rise With Many Upcoming Negative Catalysts:

Thanks for the comments. Yes, Bart that info will be shown in our Seeking Alpha article that will be off embargo tomorrow at 10am:

seekingalpha.com/.../4238331-new-age-beverages-take-spill-parabolic-rise-u...

more
All Posts

PERSONAL BLOG

Latest Posts
Apyx Medical's Stock Price Is About To Have A Liposuction - $3 Price Target (65% Downside)
Apyx sells J-Plasma technology that has failed every medical application, is now only targeted for two off-label cosmetic applications. Apyx's new CEO, Charlie Goodwin, was allegedly engaged in fraudulent sales activities at Olympus/Gyrus.

Work Experience

Education

Publications